Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-24 @ 2:44 PM
NCT ID: NCT06540859
Eligibility Criteria: Inclusion Criteria: 1. Are between 21-65 years of age. 2. SCI (non-progressive) at or above the T6 spinal segment. 3. Admitted to inpatient rehabilitation units or discharged from inpatient rehabilitation units but within 4 months since the onset on injury. 4. American Spinal Injury Association Impairment Scale (AIS) A-D for SCI. 5. Have stable medical condition that would permit participation in testing activities. 6. Willing and able to comply with all clinic visits and study-related procedures. 7. Able to understand and complete study-related questionnaires in English. 8. Have no painful musculoskeletal dysfunction, unhealed fracture, pressure sore, or active infection that may interfere with testing. 9. Are not currently pregnant or not intending to become pregnant during participation in this study. 10. Are volunteering to be involved in this study. 11. Must provide informed consent. Exclusion Criteria: 1. Have autoimmune etiology of spinal cord dysfunction/injury 2. Have history of additional neurologic disease, such as stroke, MS, etc. 3. Have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.) 4. Are ventilator dependent. 5. Have clinically significant, unmanaged, depression, ongoing alcohol and/or drug abuse. 6. Use any medication or treatment that in the opinion of the investigators indicates that it is not in the best interest of the participant to participate in this study. 7. Have Intrathecal baclofen pump. 8. Have cardiovascular, respiratory, bladder, or renal disease unrelated to SCI or presence of hydronephrosis or presence of obstructive renal stones. 9. Have severe acute medical issue that in the investigators' judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to acute urinary tract infections, pressure sores, or unstable diabetes. 10. Have pacemakers, stimulators, medication pumps in the trunk, deep brain stimulators, metallic devices in the head such as aneurysm clips/coils and stents, vagus nerve stimulators. 11. Are a member of the investigational team or his/her immediate family. 12. Have history of severe allergy (i.e. allergic reaction that could not be treated with antihistaminic medication) 13. Have malabsorption syndrome, primary hyperthyroidism, and/or hypogonadism. 14. Have a history of seizures.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 21 Years
Maximum Age: 65 Years
Study: NCT06540859
Study Brief:
Protocol Section: NCT06540859